PL2512453T5 - Granulki do preparatów farmaceutycznych, sposoby i urządzenie do ich wytwarzania - Google Patents
Granulki do preparatów farmaceutycznych, sposoby i urządzenie do ich wytwarzaniaInfo
- Publication number
- PL2512453T5 PL2512453T5 PL10793226.1T PL10793226T PL2512453T5 PL 2512453 T5 PL2512453 T5 PL 2512453T5 PL 10793226 T PL10793226 T PL 10793226T PL 2512453 T5 PL2512453 T5 PL 2512453T5
- Authority
- PL
- Poland
- Prior art keywords
- granules
- production
- methods
- devices
- pharmaceutical preparations
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
- A61K31/606—Salicylic acid; Derivatives thereof having amino groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
- A61K31/609—Amides, e.g. salicylamide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP09179877A EP2340812A1 (en) | 2009-12-18 | 2009-12-18 | Granules for pharmaceutical preparations, methods and apparatus for their production |
| PCT/EP2010/069733 WO2011073245A2 (en) | 2009-12-18 | 2010-12-15 | Granules for pharmaceutical preparations, methods and apparatus for their production |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| PL2512453T3 PL2512453T3 (pl) | 2017-03-31 |
| PL2512453T5 true PL2512453T5 (pl) | 2025-07-07 |
Family
ID=42110308
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL10793226.1T PL2512453T5 (pl) | 2009-12-18 | 2010-12-15 | Granulki do preparatów farmaceutycznych, sposoby i urządzenie do ich wytwarzania |
Country Status (28)
| Country | Link |
|---|---|
| US (2) | US8765185B2 (pl) |
| EP (2) | EP2340812A1 (pl) |
| JP (1) | JP5593396B2 (pl) |
| KR (1) | KR101882880B1 (pl) |
| CN (2) | CN102791257B (pl) |
| AR (1) | AR079536A1 (pl) |
| AU (1) | AU2010332884B2 (pl) |
| BR (1) | BR112012014935B1 (pl) |
| CA (1) | CA2784235C (pl) |
| DK (1) | DK2512453T4 (pl) |
| ES (1) | ES2612870T5 (pl) |
| FI (1) | FI2512453T4 (pl) |
| HR (1) | HRP20161639T4 (pl) |
| HU (1) | HUE031228T2 (pl) |
| IL (1) | IL220319A (pl) |
| JO (1) | JO3762B1 (pl) |
| LT (1) | LT2512453T (pl) |
| MX (2) | MX351365B (pl) |
| NL (1) | NL1038373C2 (pl) |
| NZ (1) | NZ600582A (pl) |
| PL (1) | PL2512453T5 (pl) |
| PT (1) | PT2512453T (pl) |
| RS (1) | RS55438B2 (pl) |
| RU (1) | RU2584349C2 (pl) |
| SI (1) | SI2512453T2 (pl) |
| TW (1) | TWI511723B (pl) |
| WO (1) | WO2011073245A2 (pl) |
| ZA (1) | ZA201204441B (pl) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004093883A2 (en) | 2003-04-23 | 2004-11-04 | Ferring B.V. | Sachet for a pharmaceutical composition |
| EP2350096B1 (en) | 2008-10-02 | 2019-12-11 | Salix Pharmaceuticals, Ltd. | Methods of treating hepatic encephalopathy |
| EP2340812A1 (en) | 2009-12-18 | 2011-07-06 | Ferring International Center S.A. | Granules for pharmaceutical preparations, methods and apparatus for their production |
| US20140141075A1 (en) | 2012-11-21 | 2014-05-22 | Warner Chilcott Company, Llc | 5-aminosalicylic acid capsule formulation |
| DE202017102645U1 (de) * | 2017-05-03 | 2018-08-06 | Romaco Kilian Gmbh | Ablaufvorrichtung für Presslinge einer Rundläufer-Tablettenpresse sowie Rundläufer-Tablettenpresse mit Ablaufvorrichtung |
| RU2667637C1 (ru) * | 2017-06-26 | 2018-09-21 | Гермес Арцнаймиттель ГмбХ | Фармацевтическая композиция для перорального применения, содержащая n-ацетилцистеин с маскированным вкусом |
| EP3459529A1 (en) | 2017-09-20 | 2019-03-27 | Tillotts Pharma Ag | Preparation of sustained release solid dosage forms comprising antibodies by spray drying |
| ES2938609T3 (es) | 2017-09-20 | 2023-04-13 | Tillotts Pharma Ag | Preparación de formas farmacéuticas sólidas que comprenden anticuerpos mediante estratificación de solución/suspensión |
| EP3459527B1 (en) | 2017-09-20 | 2022-11-23 | Tillotts Pharma Ag | Method for preparing a solid dosage form comprising antibodies by wet granulation, extrusion and spheronization |
| KR102161235B1 (ko) * | 2020-07-22 | 2020-09-29 | 주식회사 피티케이 | 이송 일체형 과립 제조 장치 및 방법 |
| US20240032570A1 (en) * | 2020-08-18 | 2024-02-01 | Uha Mikakuto Co., Ltd. | Oral fast-disintegrating solid food and method for manufacturing same |
| CN114472139A (zh) * | 2022-01-04 | 2022-05-13 | 安徽宏信药业发展有限公司 | 一种中药药丸干燥筛选装置 |
| CN115445902B (zh) * | 2022-09-21 | 2023-06-06 | 重庆科技学院 | 一种条形颗粒物三维尺寸分选方法及装置 |
| CN120981225A (zh) | 2023-03-28 | 2025-11-18 | 蒂洛特斯制药股份有限公司 | 用于在下部胃肠道中缓释的包含抗体的固体口服剂型 |
| CN116942532B (zh) * | 2023-09-20 | 2023-12-12 | 北京爱力佳医药科技有限公司 | 一种粉状药物制备装置 |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS57500432A (pl) | 1980-03-20 | 1982-03-11 | ||
| WO1987005232A1 (en) * | 1986-03-10 | 1987-09-11 | Cri International, Inc. | Production of improved catalyst-type particles using length and density grading |
| US4720473A (en) * | 1986-03-10 | 1988-01-19 | Cri International, Inc. | Production of improved catalyst-type particles using length and density grading |
| JPH0827133B2 (ja) | 1993-07-13 | 1996-03-21 | 不二パウダル株式会社 | 湿潤粉粒体の処理装置 |
| CA2240281C (en) | 1995-12-21 | 2007-02-27 | Farmaceutisk Laboratorium Ferring A/S | Modified release oral pharmaceutical composition containing 5-asa and method for the treatment of bowel diseases |
| US6004581A (en) * | 1995-12-21 | 1999-12-21 | Farmaceutisk Laboratorium Ferring A/S | Modified release oral pharmaceutical composition and method for the treatment of bowel diseases |
| AUPO637197A0 (en) | 1997-04-23 | 1997-05-15 | F.H. Faulding & Co. Limited | Taste-masked pharmaceutical compositions |
| DE19724181A1 (de) * | 1997-06-09 | 1998-12-10 | Bayer Ag | Multiple-unit-retard-Zubereitungen und Verfahren zu ihrer Herstellung |
| JP2000128774A (ja) | 1998-10-26 | 2000-05-09 | Tanabe Seiyaku Co Ltd | 薬物を含有する球形微粒子の製法 |
| US6146685A (en) | 1998-11-05 | 2000-11-14 | Delsys Pharmaceutical Corporation | Method of deposition a dry powder and dispensing device |
| DE59905248D1 (de) * | 1999-01-29 | 2003-05-28 | Disphar Int Bv | Pharmazeutische zusammensetzungen |
| US6735487B1 (en) | 1999-07-01 | 2004-05-11 | Ods Properties, Inc. | Interactive wagering system with promotions |
| GB0113841D0 (en) * | 2001-06-07 | 2001-08-01 | Boots Co Plc | Therapeutic agents |
| AR036797A1 (es) | 2001-10-15 | 2004-10-06 | Ferring Bv | Un metodo para preparar una composicion farmaceutica que comprende acido 5-aminosalicilico para utilizar en el tratamiento de colitis ulcerosa y enfermedades de crohn |
| CN100506234C (zh) | 2001-10-15 | 2009-07-01 | 凡林有限公司 | 用于治疗溃疡性结肠炎和克罗恩病的含有5-氨基水杨酸的药物组合物的制备方法 |
| US7445796B2 (en) | 2002-08-19 | 2008-11-04 | L. Perrigo Company | Pharmaceutically active particles of a monomodal particle size distribution and method |
| EP1470819A1 (en) * | 2003-04-23 | 2004-10-27 | Ferring B.V. | High drug load mesalazine sachet |
| WO2004093883A2 (en) | 2003-04-23 | 2004-11-04 | Ferring B.V. | Sachet for a pharmaceutical composition |
| EP1547601A1 (en) * | 2003-12-23 | 2005-06-29 | Ferring B.V. | Coating method |
| US7207505B2 (en) | 2004-06-04 | 2007-04-24 | Bender Martin P | Method for producing small granules |
| DE102004028977A1 (de) * | 2004-06-16 | 2006-01-05 | Add Advanced Drug Delivery Technologies Ltd. | Neutralpellets |
| CN101622225B (zh) | 2005-11-17 | 2015-04-15 | 泰华制药工业有限公司 | 炔丙基氨基茚分离方法 |
| EP2340812A1 (en) | 2009-12-18 | 2011-07-06 | Ferring International Center S.A. | Granules for pharmaceutical preparations, methods and apparatus for their production |
-
2009
- 2009-12-18 EP EP09179877A patent/EP2340812A1/en not_active Withdrawn
-
2010
- 2010-11-10 NL NL1038373A patent/NL1038373C2/en not_active IP Right Cessation
- 2010-12-15 RU RU2012124834/15A patent/RU2584349C2/ru active
- 2010-12-15 SI SI201031345T patent/SI2512453T2/sl unknown
- 2010-12-15 CN CN201080063456.2A patent/CN102791257B/zh active Active
- 2010-12-15 MX MX2014011350A patent/MX351365B/es unknown
- 2010-12-15 HR HRP20161639TT patent/HRP20161639T4/hr unknown
- 2010-12-15 KR KR1020127018413A patent/KR101882880B1/ko active Active
- 2010-12-15 JP JP2012543713A patent/JP5593396B2/ja active Active
- 2010-12-15 NZ NZ600582A patent/NZ600582A/en unknown
- 2010-12-15 US US13/516,145 patent/US8765185B2/en active Active
- 2010-12-15 FI FIEP10793226.1T patent/FI2512453T4/fi active
- 2010-12-15 PL PL10793226.1T patent/PL2512453T5/pl unknown
- 2010-12-15 MX MX2012006851A patent/MX2012006851A/es active IP Right Grant
- 2010-12-15 EP EP10793226.1A patent/EP2512453B2/en active Active
- 2010-12-15 JO JOP/2010/0446A patent/JO3762B1/ar active
- 2010-12-15 CN CN201610133023.9A patent/CN105769772A/zh active Pending
- 2010-12-15 HU HUE10793226A patent/HUE031228T2/en unknown
- 2010-12-15 CA CA2784235A patent/CA2784235C/en active Active
- 2010-12-15 LT LTEP10793226.1T patent/LT2512453T/lt unknown
- 2010-12-15 DK DK10793226.1T patent/DK2512453T4/da active
- 2010-12-15 ES ES10793226T patent/ES2612870T5/es active Active
- 2010-12-15 PT PT107932261T patent/PT2512453T/pt unknown
- 2010-12-15 RS RS20161111A patent/RS55438B2/sr unknown
- 2010-12-15 BR BR112012014935-0A patent/BR112012014935B1/pt active IP Right Grant
- 2010-12-15 AU AU2010332884A patent/AU2010332884B2/en active Active
- 2010-12-15 WO PCT/EP2010/069733 patent/WO2011073245A2/en not_active Ceased
- 2010-12-17 TW TW099144475A patent/TWI511723B/zh active
- 2010-12-20 AR ARP100104755A patent/AR079536A1/es not_active Application Discontinuation
-
2012
- 2012-06-12 IL IL220319A patent/IL220319A/en active IP Right Grant
- 2012-06-15 ZA ZA2012/04441A patent/ZA201204441B/en unknown
-
2014
- 2014-05-16 US US14/279,806 patent/US9114083B2/en active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL2512453T5 (pl) | Granulki do preparatów farmaceutycznych, sposoby i urządzenie do ich wytwarzania | |
| HUE062860T2 (hu) | Magas koncentrációjú gyógyszerészeti készítmények | |
| IL245328A0 (en) | Pharmaceutical composition | |
| DK2729151T3 (da) | Farmaceutisk sammensætning, fremgangsmåder til behandling og anvendelser deraf | |
| BR112012011902A2 (pt) | cápsula farmacêutica | |
| IL243932A0 (en) | Certain chemical entities, compositions and methods | |
| DK2479174T3 (da) | 6-aminoquinazolin- eller 3-cyanquinolinderivater, fremstillingsfremgangsmåder og farmaceutiske anvendelser deraf | |
| DK2699397T3 (da) | Apparater, system og fremgangsmåder til at danne pressede artikler og pressede artikler dannet derved | |
| IL222930B (en) | Chlorotoxin variants, conjugates and methods for their use | |
| DK2756073T3 (da) | Manipuleret væv til in vitro-forskningsanvendelser, anordninger deraf og fremgangsmåder til fremstilling deraf | |
| DK3415157T3 (da) | N-acyldipeptidderivater og anvendelser deraf | |
| SMT201400069B (it) | Formulazione farmaceutica | |
| EP2481739A4 (en) | DIHYDROPTERIDINONE DERIVATIVES, PROCESS FOR PREPARING THEM AND PHARMACEUTICAL USE | |
| IL230838A0 (en) | Pharmaceutical compositions | |
| IL223463A (en) | Urea History, Pharmaceutical Preparations Containing and Uses | |
| GT201200303A (es) | Formulaciones farmacéuticas | |
| BRPI1005433A2 (pt) | preparações farmacêuticas transdérmicas | |
| DK2544986T3 (da) | System og fremgangsmåde til aseptisk dosering | |
| BR112012000831A2 (pt) | compostos, composições farmacêuticas e métodos relacionados | |
| BR112013009579A2 (pt) | método e comprimido | |
| BRPI0922653A2 (pt) | preparação farmacêutica | |
| DK2488043T3 (da) | Forbedret ernæringstablet | |
| DK3210990T3 (da) | Levoisovalerylspiramycin iii og præparater, fremstillingsfremgangsmåder og anvendelser deraf | |
| BR112013008074A2 (pt) | combinações farmacêuticas | |
| EP2393836A4 (en) | SAM-6 VARIANTS, TARGET AND METHODS OF USING SAME |